gene	event	source	treatment	cancerType	doid	level	direction	url
ERBB2	AMPLIFICATION	CIViC	Trastuzumab	Breast Cancer	X	A	Responsive	http
ERBB2	AMPLIFICATION	CIViC	Panitumumab	Colorectal Cancer	X	B	Resistant	http
MET	AMPLIFICATION	iClusion	DRUP	Solid Tumors	X	B	Responsive	http
NRAS	ACTIVATION	CGI	Cetuximab	Colorectal Cancer	X	A	Resistant	http
BRCA1	INACTIVATION	iClusion	DRUP	Solid Tumors	X	B	Responsive	http
FGFR2	FUSION	CGI	Erdafitinib	Bladder Cancer	X	B	Responsive	http
ALK	FUSION	CGI	Crizotinib	Lung Adenocarcinoma	X	A	Responsive	http